Dawn Halkuff
Vermögen: 767 554 $ am 31.05.2026
Vermögen: 767 554 $ am 31.05.2026
Dawn Halkuff currently works at Society For Women's Health Research, as Director from 2017 and Xeris Biopharma Holdings, Inc., as Independent Non-Executive Director from 2021.
Ms. Halkuff also formerly worked at Ideal Protein of America, Inc., as Chief Executive Officer & Director from 2021 to 2024, Laboratoires C.O.P., Inc., as Chief Executive Officer, Xeris Pharmaceuticals, Inc., as Independent Non-Executive Director from 2018 to 2021, Pfizer Inc., as Senior Vice President-Consumer Healthcare from 2010 to 2016, WW International, Inc., as Head-Global Innovation from 2005 to 2010, WW International, Inc., as Head-Global Innovation, and TherapeuticsMD, Inc., as Chief Commercial Officer from 2016 to 2021.
Ms. Halkuff received her Masters Business Admin degree in 1997 from The Pennsylvania State University and undergraduate degree in 1992 from the University of Connecticut.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 124 603 ( 0,07 % ) | 767 554 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Direktor/Vorstandsmitglied | 05.10.2021 |
Society For Women's Health Research
Society For Women's Health Research Miscellaneous Commercial ServicesCommercial Services Engages in promoting research on biological differences in disease | Direktor/Vorstandsmitglied | 13.07.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
Ideal Protein of America, Inc.
Ideal Protein of America, Inc. Other Consumer ServicesConsumer Services Provides dieters with continuing education services and sells weight loss nutrition products | Vorstandsvorsitzender | 01.03.2024 |
Laboratoires C.O.P., Inc.
Laboratoires C.O.P., Inc. Other Consumer ServicesConsumer Services Provides medical weight loss program | Vorstandsvorsitzender | 01.01.2024 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Direktor/Vorstandsmitglied | 05.10.2021 |
| THERAPEUTICSMD, INC. | Corporate Officer/Principal | 01.09.2021 |
| PFIZER INC. | Corporate Officer/Principal | 01.10.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
WW International, Inc.
WW International, Inc. Other Consumer ServicesConsumer Services Operates weight management programs and digital subscription platform | Consumer Services |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Society For Women's Health Research
Society For Women's Health Research Miscellaneous Commercial ServicesCommercial Services Engages in promoting research on biological differences in disease | Commercial Services |
TherapeuticsMD, Inc.
TherapeuticsMD, Inc. Pharmaceuticals: MajorHealth Technology Manufactures women’s healthcare products | Health Technology |
Ideal Protein of America, Inc.
Ideal Protein of America, Inc. Other Consumer ServicesConsumer Services Provides dieters with continuing education services and sells weight loss nutrition products | Consumer Services |
Laboratoires C.O.P., Inc.
Laboratoires C.O.P., Inc. Other Consumer ServicesConsumer Services Provides medical weight loss program | Consumer Services |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen